These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. Turpie AG Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035 [TBL] [Abstract][Full Text] [Related]
3. Platelet inhibition in the management of thrombosis. Didisheim P; Kazmier FJ; Fuster V Thromb Diath Haemorrh; 1974 Sep; 32(1):21-34. PubMed ID: 4616423 [TBL] [Abstract][Full Text] [Related]
4. Drugs in the treatment of thrombo-embolic disease--part I. Bouchier-Hayes D Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642 [No Abstract] [Full Text] [Related]
5. [Current clinical results of antiplatelet medication]. Ordinas A Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391 [No Abstract] [Full Text] [Related]
6. Are agents affecting platelet functions clinically useful? Verstraete M Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299 [TBL] [Abstract][Full Text] [Related]
7. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors]. Oelz O Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707 [TBL] [Abstract][Full Text] [Related]
8. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction. Hirsh J Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733 [TBL] [Abstract][Full Text] [Related]
9. Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism. Chesebro JH; Steele PM; Fuster V Postgrad Med; 1985 Jul; 78(1):48-50, 57-71. PubMed ID: 3160013 [TBL] [Abstract][Full Text] [Related]
10. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis. Harker LA Circulation; 1986 Feb; 73(2):206-23. PubMed ID: 3510760 [TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulant treatment with and without aspirin. Altman R; Rouvier J; Gurfinkel E Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514 [TBL] [Abstract][Full Text] [Related]
12. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861 [TBL] [Abstract][Full Text] [Related]
13. The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs. Shattil SJ; Brass LF Int J Cardiol; 1983 Apr; 3(1):87-91. PubMed ID: 6852996 [No Abstract] [Full Text] [Related]
14. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). Genton E; Gent M; Hirsh J; Harker LA N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986 [No Abstract] [Full Text] [Related]
15. Platelet function inhibitors: their clinical use. Fuster V; Didisheim P Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540 [No Abstract] [Full Text] [Related]